UBS Group’s iKang Healthcare Group, Inc. KANG Stock Holding History

UBS Group’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-197,286	Closed	-$2.88M	–	8226
2017 Q1	$2.88M	Buy	+197,286	New	+$3.24M	﹤0.01%	2590
2016 Q1	–	Sell	-1,256,320	Closed	-$25.7M	–	8506
2015 Q4	$25.7M	Buy	1,256,320 +1,256,220	+1,256,220%	+$21.7M	0.02%	815
2015 Q3	$1K	Sell	100 -17,500	-99%	-$283K	﹤0.01%	8283
2015 Q2	$340K	Buy	+17,600	New	+$323K	﹤0.01%	4421

UBS Group's KANG Position: Q1 2019 in Review

UBS Group sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 182 shares — an estimated $4K sold.

UBS Group first reported a position in KANG in Q4 2014 and held it in 15 quarters. The position peaked at $215K in Q4 2015. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

UBS Group reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
UBS Group sold 182 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $4K.
UBS Group first reported a position in iKang Healthcare Group, Inc. in Q4 2014 and held it in 15 quarters.
UBS Group's iKang Healthcare Group, Inc. position peaked at $215K in Q4 2015.
0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.